Duvyzat (Givinostat) in Duchenne Muscular Dystrophy: Mechanisms, Clinical Impact, and Future Directions. (2025). Current Pharmaceutical Research, 1(3), 308-322. https://doi.org/10.63785/cpr.2025.1.3.308322